- Series: Making The Right Call
- Expires: November 28, 2023
- Credit: 0.30hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Hematology, Oncology
- Specialties: Biomarkers, NSCLC
Tumor lysis syndrome (TLS) is a serious and potentially fatal oncologic emergency that, paradoxically, is partially linked to the use of highly effective anticancer treatment. How can the management team rise to the challenge of TLS? In this activity, Anthony R. Mato, MD, MSCE, and Kristen Battiato, MSN, RN, AGNP-C, will provide an answer. Join them as they explore team-based management of TLS and provide guidance on developing TLS management plans. Throughout this program, the experts will use real-world case scenarios to demonstrate how professionals can work together to identify risk factors for TLS, recognize its laboratory and clinical symptoms, and prevent its occurrence.